Clinical Ophthalmology.
People Policies Reception of articles Other

Abstract

Improvement of quality of life in peri- and postmenopausal women
Dobrokhotova Yu.E., Borovkova E.I., Narimanova M.R.

Russian National Research Medical University named after N.I. Pirogov, Moscow

Quality of life is a subjective perception of a human’s physical, mental and social functioning, and health is its integral characteristic. Climacteric syndrome, which develops in 80% of patients during the menopause, significantly reduces the quality of life. The tactics of managing patients is determined by the clinical manifestations of the menopausal transition and those complaints that the woman considers to be significant. The use of menopausal hormone therapy does not always improve the quality of life, which is due to the multicomponent nature of the causes that lead to its violation. An integrated approach to the management of patients in the peri- and menopausal period improves the quality of life of women. In a number of cases, the use of non-hormonal drugs allows to achieve good clinical results and improve the quality of life of the patient. The results of a large-scale multicenter study conducted in Russia have proved the effectiveness of using a fixed complex of magnesium citrate with pyridoxine (Magne В6 forte) to reduce the severity of clinical manifestations and improve the quality of life of patients in the peri-menopausal period.

Key words: quality of life, climacteric syndrome, menopausal hormonal therapy, vasomotor symptom, mastodynia, magnesium citrate, pyrioxin.
For citation: Dobrokhotova Yu.E., Borovkova E.I., Narimanova M.R. Improvement of quality of life in peri- and postmenopausal women // RMJ. 2017. № 26. P. 1961–1964.

License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Read the article in PDF in Russian


Previous article
Next article
0
5180
0
77246
All articles

Распечатать